NCT05076422View on ClinicalTrials.gov

A Study to Test How Well Men Tolerate Different Doses of BI 3006337

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

March 3, 2023

Study Completion Date

March 3, 2023

Conditions
Healthy
Interventions
DRUG

BI 3006337

BI 3006337

DRUG

Placebo

Placebo

Trial Locations (2)

2650

SGS Life Science Services - Clinical Research, Edegem

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY